-

SEVER Life Sciences B.V. Signs Agreement to Sell Nordic Group B.V. to Alfasigma S.p.A.
-SEVER Life Sciences B.V. (“SEVER”) today announced that it has signed a Share Purchase Agreement (“SPA”) for the sale of…
0 -

Nordic Pharma Announces Launch of Lacrifill® Canalicular Gel in the United Kingdom (UK)
-Theale, United Kingdom – 23rd February 2026 – Nordic Pharma UK Limited, a subsidiary of Nordic group B.V, an international…